NEOGENOMICS INC 8K

NeoGenomics, Inc. executed an indenture to issue $316.25 million of 0.75% Convertible Senior Notes due 2032 with standard conversion, redemption, and fundamental change provisions.

NeoGenomics, Inc. entered into an indenture dated June 22, 2026, with U.S. Bank Trust Company, National Association, as trustee, providing for the issuance of up to $316,250,000 aggregate principal amount of 0.75% Convertible Senior Notes due July 1, 2032, which bear semi-annual interest, are convertible into NeoGenomics common stock under specified conditions and settlement methods, and include customary covenants, events of default, optional and cleanup redemptions, and noteholder put rights upon certain fundamental change events.

Filing Facts

CIK

1077183

Ticker

-

Form

8K

Source Type

sec

Accession

0001077183-26-000037

Alert Tier

8